This study is an indication of what Irish investigators can achieve when they work together. It will be a unique achievement when completed in the final quarter of 2001. It will be an Irish designed study set up to answer an important clinical question fully completed in Ireland. In November of this year it enrolled its 200 patient, the target of 260 patients will be reached in the fourth quarter or earlier.
